This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Allscripts Wand™ 2.0 For Enterprise EHR Is Generally Available

Stocks in this article: MDRX

CHICAGO, Aug. 20, 2013 /PRNewswire/ -- The highly-anticipated Allscripts Wand™ 2.0 for Enterprise EHR is now generally available. In a busy physician practice, clinicians and physicians are moving quickly from patient to patient. Efficient throughput is essential to their operational success. Wand is the native iPad™ application that couples the latest in tablet technology with the latest in user-experience innovation for a revolutionary approach to how physicians practice medicine.

Allscripts will be demoing the latest version of Wand this week at The Allscripts Client Experience (ACE), August 21-23 at Chicago's McCormick Place.

This enhanced version of Wand contains the functionality that clinicians and physicians alike need to complete a patient visit with one mobile device. Whether it's reviewing the patient chart before entering the exam room, updating the patient's history during a consultation, refilling electronic prescriptions while rounding in the hospital or reviewing the next day's appointments from home, Wand supports the physician's workflow, wherever he or she is. Wand was built to help physicians collect the electronic information they need without interfering with the important physician-patient relationship.

"Wand for Enterprise offers physicians flexibility," said Dr. Brian Keeffe, a cardiologist and Chief Medical Advisor for Electronic Health Records at Marin Medical Practice Concepts. "The ability to create notes on the go when you are seeing up to 25 patients per day is invaluable."

Other key features of the enhanced version of Wand include:

  • Complete Clinical documentation
  • Place all types of orders
  • Easily attach photos to a patient's chart
  • Drop visit charges

"We listened to our clients and broke new ground with the 2.0 version of Wand for Enterprise," said Stanley Crane, Chief Innovation Officer for Allscripts. "What we have delivered is a mobile tool with a streamlined workflow and faster access to critical data – where and when the physicians need it most – in their hands at the point of care."

Wand for Enterprise is the latest in a long line of mobility innovation from Allscripts. Wand for Professional was unveiled in April 2012. In 2010, the company released Sunrise Mobile MDII for iPad, giving hospitals providers remote access to many daily activities, expanding on Sunrise Mobile MD for iPhone™. And with Allscripts Remote, available since 2009, ambulatory EHR users can access key clinical features after hours on virtually any smartphone. Wand for Enterprise takes the next step by adding more features and a native iPad interface to put essential clinical information at the fingertips of the mobile healthcare professional.

For more information or to download the application, visit the iTunes App Store.

About Allscripts Allscripts (NASDAQ: MDRX) delivers the insights that healthcare providers require to generate world-class outcomes. The company's Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create a  Connected Community of Health™ for physicians, hospitals and post-acute organizations.  To learn more about Allscripts, please visit  www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2013 Allscripts Healthcare, LLC. All Rights Reserved.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs